Regulation of lymphotoxin-β by tumor necrosis factor, phorbol myristate acetate, and ionomycin in Jurkat T cells

Journal of Interferon and Cytokine Research

Volumn 21, Issue 11, 2001, Pages 921-930

  Voon, D C ^a   Subrata, L S ^a   Abraham, L J ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

IONOMYCIN; LYMPHOTOXIN; MESSENGER RNA; PHORBOL 13 ACETATE 12 MYRISTATE; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CONTROLLED STUDY; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; INFLAMMATION; LEUKEMIA CELL LINE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN STABILITY; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

GENES, REPORTER; HUMANS; IONOMYCIN; IONOPHORES; JURKAT CELLS; KINETICS; LYMPHOTOXIN-ALPHA; LYMPHOTOXIN-BETA; MEMBRANE PROTEINS; PROMOTER REGIONS (GENETICS); RNA STABILITY; RNA, MESSENGER; T-LYMPHOCYTES; TETRADECANOYLPHORBOL ACETATE; TRANS-ACTIVATION (GENETICS); TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 0035677859     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/107999001753289532     Document Type: Article

References (41)

1. Lymphotoxin beta, a novel member of the TNF family that forms a heteromeric complex with lymphotoxin on the cell surface
2. Lymphotoxin is expressed as a heteromeric complex with a distinct 33-kDa glycoprotein on the surface of an activated human T cell hybridoma
3. Lymphotoxin and an associated 33-kDa glycoprotein are expressed on the surface of an activated human T cell hybridoma
4. Expression of membrane-associated lymphotoxin/tumor necrosis factor-beta on human lymphokine-activated killer cells
5. Characterization of surface lymphotoxin forms. Use of specific monoclonal antibodies and soluble receptors
6. Proinflammatory responses are efficiently induced by homotrimeric but not heterotrimeric lymphotoxin ligands
7. A lymphotoxin beta specific receptor
8. Abnormal development of secondary lymphoid tissues in lymphotoxin beta-deficient mice
9. Lymphotoxin-alpha-deficient mice. Effects on secondary lymphoid organ development and humoral immune responsiveness
10. Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin
11. Independent signals regulate development of primary and secondary follicle structure in spleen and mesenteric lymph node
12. Distinct roles in lymphoid organogenesis for lymphotoxins alpha and beta revealed in lymphotoxin beta-deficient mice
13. Role of lymphotoxin and the type I TNF receptor in the formation of germinal centers
14. Membrane lymphotoxin is required for the development of different sub-populations of NK T cells
15. Mature follicular dendritic cell networks depend on expression of lymphotoxin beta receptor by radioresistant stromal cells and of lymphotoxin beta and tumor necrosis factor by B cells
16. Requirement for membrane lymphotoxin in natural killer cell development
17. Mice with a targeted mutation in lymphotoxin-alpha exhibit enhanced tumor growth and metastasis: Impaired NK cell development and recruitment
18. Signal via lymphotoxin-beta R on bone marrow stromal cells is required for an early checkpoint of NK cell development
19. Activation of the lymphotoxin beta receptor by cross-linking induces chemokine production and growth arrest in A375 melanoma cells
20. Differential induction of adhesion molecule and chemokine expression by LTalpha3 and LTalphabeta in inflammation elucidates potential mechanisms of mesenteric and peripheral lymph node development
21. Cytokine patterns in tuberculous and sarcoid granulomas - Correlations with histopathologic features of the granulomatous response
22. Early cytokine and chemokine gene expression during Pseudomonas aeruginosa corneal infection in mice
23. Functional analysis of the lymphotoxin-beta promoter - Sequence requirements for PMA activation
24. Tumor necrosis factor and interleukin-1 lead to phosphorylation and loss of I kappa B alpha: A mechanism for NF-kappa B activation
25. Expression of surface lymphotoxin and tumor necrosis factor on activated T, B, and natural killer cells
26. Constitutive synthesis of tumor necrosis factor in the thymus
27. Tumor necrosis factor-beta in human pregnancy and labor
28. LIGHT, a new member of the TNF superfamily, and lymphotoxin alpha are ligands for herpesvirus entry mediator
29. Characterization of the lymphotoxin-beta (LT-β) gene
30. Differential regulation of lymphotoxin (LT), lymphotoxin-β (LT-β), and the TNF-alpha in murine T cell clones activated through the TCR
31. Characterization of the receptor for tumor necrosis factor (TNF) and lymphotoxin (LT) on human T lymphocytes
32. Studies of membrane-associated and soluble (secreted) lymphotoxin in human lymphokine-activated T-killer cells in vitro
33. Interleukin-1 stimulates diacylglycerol production in T lymphocytes by a novel mechanism
34. Low-affinity binding of interleukin-1 beta and intracellular signaling via NF-kappa B identify Fit-1 as a distant member of the interleukin-1 receptor family
35. Regulation of PtdIns-3-kinase and the guanine nucleotide binding proteins p21ras during signal transduction by the T cell antigen receptor and the interleukin-2 receptor
36. Lipopolysaccharide-induced expression of TNF-alpha gene in the macrophage cell line ANA-1 is regulated at the level of transcription processivity
37. The NF-kappa B and I kappa B proteins: New discoveries and insights
38. Activation of multiple NF-kappa B/Rel DNA-binding complexes by tumor necrosis factor
39. The tumor necrosis factor signaling complex - Choosing a path toward cell death or cell proliferation
40. + T cell responses: The alternative approaches
41. Tumor necrosis factor in the pathophysiology of infection and sepsis